title: High dose chemotherapy in ovarian cancer.
authors.affiliation: GINECO trials, Departement of Hematology and Medical Oncology, Hôtel-Dieu, Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Pujade-Lauraine
authors.forename: H
authors.initials: H
authors.lastname: Curé
authors.forename: C
authors.initials: C
authors.lastname: Battista
authors.forename: J P
authors.initials: JP
authors.lastname: Guastalla
authors.forename: B
authors.initials: B
authors.lastname: Chiurazzi
authors.forename: M
authors.initials: M
authors.lastname: Fabbro
authors.forename: N
authors.initials: N
authors.lastname: Tubiana-Mathieu
authors.forename: H
authors.initials: H
authors.lastname: Bourgeois
authors.forename: B
authors.initials: B
authors.lastname: Lioure
authors.forename: D
authors.initials: D
authors.lastname: Paraiso
authors.forename: J P
authors.initials: JP
authors.lastname: Lotz
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D002945:Cisplatin / Q000008:administration & dosage* / Q000494:pharmacology; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D016179:Granulocyte Colony-Stimulating Factor; D002945:Cisplatin